Home

Targeting Prevention to Reduce the High Human Toll of Rare Cancers

Each Rare Cancer Accounts for less than 40,000 new cases each year.

At the Rare Cancers Prevention and Interception workshop this year, cancer researchers from across the United States, Canada, and the United Kingdom and from across disciplines sought to address many of the issues that can hamper research progress for these diseases.  

Research Highlights: Looking Deep into Genetic Changes that Increase Colorectal Cancer Risk to Prevent or Detect Inherited Cancers

Illustration of a DNA strand breaking apart in a section.

Emergency Notice

People in the path of recent hurricanes may need help continuing their cancer care. The National Cancer Institute’s (NCI) Cancer Information Specialists can refer people who have been displaced by Hurricane Helene to nearby cancer centers or NCI Community Oncology Research Program (NCORP) sites to continue their care.

  • Call 1-800-4-CANCER (1-800-422-6237)
  • Online LiveHelp® chat

M-F, 9:00 a.m. – 9:00 p.m. ET

NCI Emergency Resources

Latest News

Read All News

DCP Participation in National Academies of Science Engineering, and Medicine (NASEM) MCD Workshop: Opportunities and Challenges for the Development and Adoption of Multicancer Detection Tests – October 28-29, 2024

This hybrid NASEM MCD workshop will examine the state of the science for clinical use of multi-cancer detection (MCD) tests. The NCI Division of Cancer Prevention staff will present on Monday, October 28. View the MCD Public…

October 17 | DCP News

DCP Participation at Biomedical Engineering Society (BMES) Annual Meeting - October 24, 2024

The Biomedical Engineering Society (BMES) Annual Meeting will be held October 23-26, 2024, in Baltimore. “Synergizing Research and Cultural Excellence” is this year’s theme. The NCI Division of Cancer Prevention staff will…

October 15 | DCP News

G7 Lung Cancer Screening Seminar, TACPAD Virtual Meeting, NOFOs, and More

Emergency Notice, Upcoming Events, Latest News, Notice of Funding Opportunities (NOFOs), Reminders

October 1 | DCP Updates

NCORP-supported Research Shows Olanzapine May Reduce Chemotherapy-Induced Nausea

Researchers have found that olanzapine may be more effective in controlling severe nausea and improving the quality of life in patients with cancer who are undergoing treatment with chemotherapy, according to new findings…

September 30 | ASCO News

Meetings and
Events

Review All Our Meetings
and Events

Translational Advances in Cancer Prevention Agent Development (TACPAD) – 3rd Biennial Virtual Meeting

Date(s):
  • -
  • -
  • -
Location: Virtual

Symptom Science in the Context of Cancer Caregiving

Date(s):
  • -
Location: Virtual via ZoomGov

The Principles and Practice of Cancer Precision Prevention Studies

Date(s):
  • -
Location: Virtual via Webex